Contents

Issue 48 • February 2022

Theranos: a wake-up call for the test market

The Theranos court case may help highlight an important loophole in FDA regulation 

IN DEPTH

Medical devices for rare diseases the unmet need

Comment

3D printing will languish in healthcare  -until it explodes

Briefing

Industry news

Medical industry briefing

Covid-19 briefing

Comment

3D printing will languish in healthcare – until it explodes

Public healthcare systems will be last in line for surgical robotic systems

The pandemic has increased the use of virtual application services

In Depth

Theranos: a wake-up call for the lab-developed test market

Medical devices for rare diseases: the unmet need

3D printing for point-of-care device manufacturing - healthcare hero or hazard?

IQVIA on AI’s potential to match patients to trials and improve trial diversity

UK med tech faces regulatory uncertainty post-Brexit

In Data

The medical devices companies leading the way in cybersecurity

IoT innovation among medical industry companies has dropped off in the last year

Europe is seeing a hiring boom in medical industry data analytics roles

Markets and indices

Macro-economic data